Vitamin D in the General Population of Young Adults with Autism in the Faroe Islands

Journal of Autism and Developmental Disorders

Volumn 44, Issue 12, 2014, Pages 2996-3005

  Kočovská, Eva ^a,b   Andorsdóttir, Guðrið ^c   Weihe, Pál ^d   Halling, Jónrit ^d   Fernell, Elisabeth ^a,e   Stóra, Tormóður ^f   Biskupstø, Rannvá ^c   Gillberg, I Carina ^a   Shea, Robyn ^g   Billstedt, Eva ^a   Bourgeron, Thomas ^h,i   Minnis, Helen ^b   Gillberg, Christopher ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c Ministry of Health Affairs   (Faroe Islands)

^d FAROESE HOSPITAL SYSTEM   (Faroe Islands)

^e SKARABORG HOSPITAL   (Sweden)

^f National Hospital of the Faroe Islands   (Faroe Islands)

^g CITY HOSPITAL   (United Kingdom)

^h INSTITUT PASTEUR   (France)

ⁱ INSTITUT PASTEUR   (France)

Author keywords

ASD; Autism; Calcitriol; Faroe Islands; Total population; Vitamin D

Indexed keywords

VITAMIN D;

ADOLESCENT; AUTISTIC DISORDER; BLOOD; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DENMARK; FEMALE; HEALTH SURVEY; HUMAN; MALE; PROCEDURES; RISK FACTOR; VITAMIN D DEFICIENCY; YOUNG ADULT;

ADOLESCENT; AUTISTIC DISORDER; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DENMARK; FEMALE; HUMANS; MALE; POPULATION SURVEILLANCE; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84930921267     PISSN: 01623257     EISSN: 15733432     Source Type: Journal    
DOI: 10.1007/s10803-014-2155-1     Document Type: Article

References (52)

1. Adams, J. S., & Hewison, M. (2010). Update in vitamin D. Journal of Clinical Endocrinology and Metabolism,95, 471–478.
2. Agborsangaya, C., Toriola, A. T., Grankvist, K., Surcel, H. M., Holl, K., Parkkila, S., et al. (2010). The effects of storage time, sampling season on the stability of serum 25-hydroxy vitamin D, androstenedione. Nutrition and Cancer,62, 51–57.
3. Ahn, J., Yu, K., Stolzenberg-Solomon, R., Simon, K. C., McCullough, M. L., Gallicchio, L., et al. (2010). Genome-wide association study of circulating vitamin D levels. Human Molecular Genetics,19, 2739–2745.
4. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Association.
5. Cannell, J. J., & Grant, W. B. (2013). What is the role of vitamin D in Autism? Dermato-Endocrinology,5, 1–6.
6. Coleman, M., & Gillberg, C. (2012). The autisms (4th ed., pp. 286–302). Oxford: Oxford University Press.
7. Dalgård C., Petersen, M. S., Schmedes, A.V., Brandslund, I., Weihe, P., & Grandjean, P. (2010). British Journal of Nutrition, 104, 914–918.
8. De Souza Tostes, M. H., Polonini, H. C., Gattaz, W. F., Raposo, N. R. B., & Baptista, E. B. (2012). Low serum levels of 25-hydroxyvitamin D (25-OHD) in children with autism. Trends in Psychiatry and Psychotherapy,34, 161–163.
9. Dealberto, M. J. (2011). Prevalence of autism according to maternal immigrant status and ethnic origin. Acta Psychiatrica Scandinavica,123, 339–348.
10. Ellefsen, A., Kampmann, H., Billstedt, E., Gillberg, I. C., & Gillberg, C. (2007). Autism in the Faroe Islands. An epidemiological study. Journal of Autism and Developmental Disorders,37, 437–444.
11. Eyles, D. W., Smith, S., Kinobe, R., Hewison, M., & McGrath, J. J. (2005). Distribution of the vitamin D receptor and 1α-hydroxylase in human brain. Journal of Chemical Neuroanatomy,29, 21–30.
12. Eyles, D. W., Burne, T. H., & McGrath, J. J. (2013). Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Frontiers in Neuroendocrinology,34, 47–64.
13. Feldman, D., Pike, W. J., & Adams, J. S. (2011). Vitamin D. Amsterdam: Elsevier.
14. Fernell, E., Barnevik-Olsson, M., Bågenholm, G., Gillberg, C., Gustafsson, S., & Sääf, M. (2010). Serum levels of 25-hydroxyvitamin D in mothers of Swedish and of Somali origin who have children with and without autism. Acta Paediatrica,99, 743–747.
15. Fu, L., Yun, F., Oczak, M., Wong, B. Y. L., Vieth, R., & Cole, D. E. C. (2009). Common genetic variants of the vitamin D binding protein (DBP) predict differences in response of serum 25-hydroxyvitamin D [25(OH)D] to vitamin D supplementation. Clinical Biochemistry,42, 1174–1177.
16. Garcion, E., Wion-Barbot, N., Montero-Menei, C. N., Berger, F., & Wion, D. (2002). New clues about vitamin D functions in the nervous system. Trends in Endocrinology and Metabolism,13, 100–105.
17. Gardener, H., Spiegelman, D., & Buka, S. L. (2009). Prenatal risk factors for autism: Comprehensive meta-analysis. The British Journal of Psychiatry,195, 7–14.
18. Gentile, I., Zappulo, E., Militerni, R., Pascotto, A., & Borgia, G. (2013). Etiopathogenesis of autism spectrum disorders: Fitting the pieces of the puzzle together. Medical Hypotheses,81, 26–35.
19. Giarelli, E., Wiggins, L. D., Rice, C. E., Levy, S. E., Kirby, R. S., Pinto-Martin, J., et al. (2010). Sex differences in the evaluation and diagnosis of autism spectrum disorders among children. Disability and Health Journal, 3, 107–116.
20. Gillberg, C. (2010). The ESSENCE in child psychiatry: Early symptomatic syndromes eliciting neurodevelopmental clinical examinations. Research in Developmental Disabilities,31, 1543–1551.
21. Gong, Z. L., Luo, C. M., Wang, L., Shen, L., Wei, F., Tong, R. J., et al. (2014). Serum 25-hydroxyvitamin D levels in Chinese children with autism spectrum disorders. NeuroReport,25, 23–27.
22. Grant, W. B., & Soles, C. M. (2009). Epidemiologic evidence supporting the role of maternal vitamin D deficiency as a risk factor for the development of infantile autism. Dermato-Endocrinology,1, 223–228.
23. Hayes, C. E., Nashold, F. E., Spach, K. M., & Pedersen, L. B. (2003). The immunological functions of the vitamin D endocrine system. Cellular and Molecular Biology (Noisy-le-grand),49, 277–300.
24. Heaney, R. P., & Holick, M. F. (2011). Why the IOM recommendations for vitamin D are deficient. Journal of Bone and Mineral Research, 26, 455–457.
25. Hennekens, C. H., Buring, J. E., & Mayrent, S. L. (Eds.). (1987). Epidemiology in medicine (pp. 40–41). Philadelphia: Lippincott Williams & Wilkins.
26. Hiraki, L. T., Major, J. M., Chen, C., Cornelis, M. C., Hunter, D. J., Rimm, E. B., et al. (2013). Exploring the genetic architecture of circulating 25-hydroxyvitamin D. Genetic Epidemiology,37, 92–98.
27. Holick, M. F. (2007). Vitamin D deficiency. New England Journal of Medicine,357, 266–281.
28. Holick, M. F., Binkley, N. C., Bischoff-Ferrari, H. A., Gordon, C. M., Hanley, D. A., Heaney, R. P., et al. (2011). Evaluation, treatment, and prevention of vitamin D deficiency: An endocrine society clinical practice guideline. The Journal of Clinical Endocrinology and Metabolism,96, 1911–1930.
29. Humble, M. B., Gustafsson, S., & Bejerot, S. (2010). Low serum levels of 25-hydroxyvitamin D (25-OHD) among psychiatric out-patients in Sweden: Relations with season, age, ethnic origin and psychiatric diagnosis. The Journal of Steroid Biochemistry and Molecular Biology,121, 467–470.
30. Kočovská, E., Billstedt, E., Ellefsen, Á., Kampmann, H., Gillberg, I. C., Biskupstø, R., et al. (2013). Autism in the Faroe Islands: Diagnostic stability from childhood to early adult life. The Scientific World Journal, 2013, 7. http://dx.doi.org/10.1155/2013/592371.
31. Kočovská, E., Biskupstø, R., Gillberg, I. C., Ellefsen, Á., Kampmann, H., Stórá, T., et al. (2012b). The rising prevalence of autism: A prospective longitudinal study in the Faroe Islands. Journal of Autism and Developmental Disorders,42, 1959–1966.
32. Kočovská, E., Fernell, E., Billstedt, E., Minnis, H., & Gillberg, C. (2012a). Vitamin D and autism: Clinical review. Research in Developmental Disabilities,33, 1541–1550.
33. Kolevzon, A., Gross, R., & Reichenberg, A. (2007). Prenatal and perinatal risk factors for Autism. Archives of Pediatrics and Adolescent Medicine,161, 326–333.
34. Kopp, S., Kelly, K., & Gillberg, C. (2010). Girls with social and/or attention deficits: A descriptive study of 100 clinic attenders. Journal of Attention Disorders, 14, 167–181.
35. Lord, C., Rutter, M., Goode, S., Heemsbergen, J., Jordan, H., Mawhood, L., et al. (1989). Autism diagnostic observation schedule: A standardized observation of communicative and social behavior. Journal of Autism and Developmental Disorders,19, 185–212.
36. Meguid, N. A., Hashish, A. F., Anwar, M., & Sidhom, G. (2010). Reduced serum levels of 25-hydroxy and 1, 25-dihydroxy vitamin D in Egyptian children with autism. Journal of Alternative and Complementary Medicine,16, 641–645.
37. Molloy, C. A., Kalkwarf, H. J., Manning-Courtney, P., Mills, J. L., & Hediger, M. L. (2010). Plasma 25(OH)D concentration in children with autism spectrum disorder. Developmental Medicine and Child Neurology,52, 969–971.
38. Mostafa, G. A., & AL-Ayadhi, L. Y. (2012). Reduced serum concentrations of 25-hydroxy vitamin D in children with autism: Relation to autoimmunity. Journal of Neuroinflammation,9, 201–207.
39. Munger, K. L., Levin, L. I., Massa, J., Horst, R., Orban, T., & Ascherio, A. (2012). Preclinical serum 25-hydroxyvitamin D levels and risk of type 1 diabetes in a cohort of US military personnel. American Journal of Epidemiology,177, 411–419.
40. Novakovic, B., Sibson, M., Ng, H. K., Manualpillai, U., Rakyan, V., Down, T., et al. (2009). Placenta-specific methylation of the vitamin D 24-hydroxylase gene. The Journal of biological chemistry,284, 14838–14848.
41. Nseir, W., Mograbi, J., Abu-Rahmeh, Z., Mahamid, M., Abu-Elheja, O., & Shalata, A. (2012). The association between vitamin D levels and recurrent group A streptococcal tonsillopharyngitis in adults. International Journal of Infectious Diseases,16, e735–e738.
42. Orton, S.-M., Herrera, B. M., Yee, I. M., Valdar, W., Ramagopalan, S. V., Sadovnick, A. D., et al. (2006). Sex ratio of multiple sclerosis in Canada: A longitudinal study. Lancet Neurology,5, 932–936.
43. Priemel, M., von Domarus, C., Klatte, T. O., Kessler, S., Schlie, J., Meier, S., et al. (2010). Bone mineralization defects and vitamin D deficiency: Histomorphometric analysis of iliac crest biopsies and circulating 25-hydroxyvitamin D in 675 patients. Journal of Bone and Mineral Research, 25, 305–312.
44. Ramagopalan, S. V., Heger, A., Berlanga, A. J., Maugeri, N. J., Lincoln, L. R., Burrell, A., et al. (2010). A ChIP-seq-defined genome-wide map of vitamin D receptor binding: Associations with disease and evolution. Genome Research,20, 1352–1360.
45. Schöttker, B., Jansen, E. H., Haug, U., Schomburg, L., Köhrle, J., & Brenner, H. (2012). Standardization of misleading immunoassay based 25-hydroxy-vitamin D levels with liquid chromatography tandem-mass spectrometry in a large cohort study. PLoS ONE,7, e48774.
46. Shea, R. L., & Berg, J. D. (2013). Measuring 25-hydroxy vitamin D in haemolysed whole blood samples. Annals of Clinical Biochemistry,50(supplement 1), 25–26.
47. Spach, K. M., & Hayes, C. E. (2005). Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice. The Journal of Immunology,175, 4119–4126.
48. Stamm, C., Friehs, I., Ho, S. Y., Moran, A. M., Jonas, R. A., & del Nido, P. J. (2001). Congenital supravalvar aortic stenosis: A simple lesion? European Journal of Cardio-Thoracic Surgery,19, 195–202.
49. Wechsler, D. (1981). Wechsler adult intelligence scale-revised, 1981. San Antonio, TX: Psychological Corporation.
50. Wechsler, D. (1992). Wechsler Intelligence Scale for Children (3rd ed.). London: Psychological Corporation.
51. Wing, L., Leekam, S. R., Libby, S. J., Gould, J., & Larcombe, M. (2002). The diagnostic interview for social and communication disorders: Background, inter-rater reliability and clinical use. Journal of Child Psychology and Psychiatry,43, 307–325.
52. World Health Organization. (1993). The ICD-10 classification of mental and behavioural disorders. Diagnostic criteria for research. Geneva: World Health Organisation.